Ligand Pharmaceuticals Inc.(LGND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LGND Ligand Pharmaceuticals Inc.

圣诞节休市 12-24 13:00:00 EST

113.38

-0.42

-0.37%

盘后113.38

+0.000.00%

16:04 EST

最高114.58	最低111.98	成交量5.87万
今开113.50	昨收113.80	日振幅2.28%
总市值21.42亿	流通市值21.00亿	总股本1,890万
成交额666.18万	换手率0.32%	流通股本1,852万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LGND","market":"US","secType":"STK","nameCN":"Ligand Pharmaceuticals Inc.","latestPrice":113.38,"timestamp":1735063200000,"preClose":113.8,"halted":0,"volume":58748,"hourTrading":{"tag":"盘后","latestPrice":113.38,"preClose":113.38,"latestTime":"16:04 EST","volume":53,"amount":6529.98,"timestamp":1735074272544},"delay":0,"floatShares":18521550,"shares":18895373,"eps":2.471661,"marketStatus":"圣诞节休市","marketStatusCode":7,"change":-0.42,"latestTime":"12-24 13:00:00 EST","open":113.5,"high":114.58,"low":111.98,"amount":6661824.04428,"amplitude":0.022847,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.471661,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735203600000},"adr":0,"listingDate":721976400000,"adjPreClose":113.8,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":114.99,"preClose":113.8,"latestTime":"04:28 EST","volume":7,"amount":806.6600080000001,"timestamp":1735032517962},"postHourTrading":{"tag":"盘后","latestPrice":113.38,"preClose":113.38,"latestTime":"16:04 EST","volume":53,"amount":6529.98,"timestamp":1735074272544},"volumeRatio":0.5268284307872972,"impliedVol":0.4128,"impliedVolPercentile":0.1429},"requestUrl":"/m/hq/s/LGND","defaultTab":"news","newsList":[{"id":"2492159462","title":"Ligand Pharmaceuticals Incorporated盘中异动 临近收盘急速下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159462?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:40","pubTimestamp":1734554447,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时40分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速跳水5.21%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.83%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3230.10%、678.34%、350.90%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、147.29%、105.17%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044047a1f95823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044047a1f95823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","LU0566484027.USD","LGND","LGNZZ","BK4007","LGNXZ","LGNYZ","BK4139","LGNDZ"],"gpt_icon":0},{"id":"2491469200","title":"Ligand Pharmaceuticals Incorporated盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491469200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491469200?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:50","pubTimestamp":1734360606,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时50分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速拉升5.00%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Viridian Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为43.41%、32.86%、30.98%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225006ab7c9d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225006ab7c9d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","BK4007","LGNXZ","LU1559883803.SGD","LGND","BK4139","LGNDZ","LGNYZ","LU0566484027.USD"],"gpt_icon":0},{"id":"2491512233","title":"Ligand Pharmaceuticals Incorporated盘中异动 临近收盘快速跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491512233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491512233?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:43","pubTimestamp":1734036198,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时43分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速跳水5.24%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为1.65%。其相关个股中，Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为4327.26%、1267.12%、98.34%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304431895e9434d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121304431895e9434d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","BK4139","BK4007","LU0566484027.USD","LGNXZ","LGND","LU1559883803.SGD","LGNYZ","LGNDZ"],"gpt_icon":0},{"id":"2488966885","title":"美国研究综述-花旗集团、Salesforce、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2488966885","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488966885?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:11","pubTimestamp":1733209873,"startTime":"0","endTime":"0","summary":"美国研究综述-花旗集团、Salesforce、Zscaler路透社12月3日 - 华尔街证券分析师周二调整了对花旗集团、Salesforce 和 Zscaler 等多家美国上市公司的评级和目标价。* Salesforce Inc CRM.N：D.A. Davidson将目标价从250美元上调至300美元 * State Street Corp STT.N：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。* Zscaler Inc ZS.O：Piper Sandler将目标价从215美元上调至235美元以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N40EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZS","GEV","STT","FDX","PTCT","LGND","HOLX","RVMD","ARES","CRM","C"],"gpt_icon":1},{"id":"2485417845","title":"Ligand Pharmaceuticals Incorporated盘中异动 急速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485417845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485417845?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:00","pubTimestamp":1732208422,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时00分，Ligand Pharmaceuticals Incorporated股票出现异动，股价快速拉升5.29%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Briacell Therapeutics Corp.、Conduit Pharmaceuticals Inc.、Cidara Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为913.64%、496.34%、354.13%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010023971a7ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010023971a7ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LGNZZ","LGNXZ","BK4007","LU1559883803.SGD","LGND","LU0566484027.USD","BK4139","LGNDZ"],"gpt_icon":0},{"id":"2484468510","title":"Ligand Pharmaceuticals Incorporated2024财年第三财季实现净利润-7.17百万美元，同比增加30.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484468510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484468510?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:02","pubTimestamp":1731772975,"startTime":"0","endTime":"0","summary":"11月17日，Ligand Pharmaceuticals Incorporated公布财报，公告显示公司2024财年第三财季净利润为-7.17百万美元，同比增加30.19%；其中营业收入为51.81百万美元，同比增加57.62%，每股基本收益为-0.39美元。从资产负债表来看，Ligand Pharmaceuticals Incorporated总负债1.14亿美元，其中短期债务1.09百万美元，资产负债比为8.38，流动比率为0.13。机构评级：截至2024年11月17日，当前有8家机构对Ligand Pharmaceuticals Incorporated目标价做出预测，其中目标均价为140.25美元，其中最低目标价为125.00美元，最高目标价为157.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000355a23e06ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000355a23e06ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LGNXZ","LGNYZ","LGNDZ","LGND"],"gpt_icon":0},{"id":"2483384713","title":"Ligand Pharmaceuticals Incorporated盘中异动 股价大跌5.08%报115.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384713?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:18","pubTimestamp":1731604732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时18分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速下跌5.08%。截至发稿，该股报115.88美元/股，成交量5.7477万股，换手率0.30%，振幅7.99%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.71%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115011853a23834fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115011853a23834fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LGNZZ","LGNXZ","BK4007","LU1559883803.SGD","LGND","LU0566484027.USD","BK4139","LGNDZ"],"gpt_icon":0},{"id":"2481101287","title":"Ligand Pharmaceuticals Incorporated盘中异动 大幅下挫5.36%报122.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101287?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:35","pubTimestamp":1731076513,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时35分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速跳水5.36%。截至发稿，该股报122.94美元/股，成交量1.3674万股，换手率0.07%，振幅1.76%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.33%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223513a224c529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223513a224c529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGND","BK4139","LU0566484027.USD","LGNXZ","LGNDZ","LGNZZ","LU1559883803.SGD","LGNYZ","BK4007"],"gpt_icon":0},{"id":"2481425959","title":"Ligand Pharmaceuticals Incorporated盘中异动 临近收盘股价大涨5.24%报116.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481425959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481425959?lang=zh_cn&edition=full","pubTime":"2024-11-07 05:00","pubTimestamp":1730926833,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日05时00分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅拉升5.24%。截至发稿，该股报116.95美元/股，成交量17.7639万股，换手率0.97%，振幅4.38%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.44%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107050033aba75d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107050033aba75d6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","LGNDZ","LGNZZ","LGNYZ","LGNXZ","LU0566484027.USD","LGND","BK4139","BK4007"],"gpt_icon":0},{"id":"1132999592","title":"潜力股集结！下周公布业绩的这15家公司股价总是因财报超预期而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1132999592","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132999592?lang=zh_cn&edition=full","pubTime":"2024-11-01 14:56","pubTimestamp":1730444212,"startTime":"0","endTime":"0","summary":"接下来一周公布业绩的几只股票可能比其竞争对手更具优势。在已公布业绩的325家标普500公司中，超过74%的公司发布的每股收益超出预期，而61%的公司还超出了分析师的营收预期。Zillow的业绩超预期率为83%，且在财报发布后平均上涨1.6%。其平均目标价意味着潜在的7%上涨空间。这一最新预测意味着Zillow的股价自周三的收盘价可能上涨39%。其股票今年下跌了4%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/56ca27b82c694029da673822e5e44e92","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/56ca27b82c694029da673822e5e44e92"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"潜力股集结！下周公布业绩的这15家公司股价总是因财报超预期而上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNG","TTD","VERX","BILL","WK","PINS","ZG","LOPE","HUBS","FN","FIVN","DIN","RAMP","LGND","CARG"],"gpt_icon":1},{"id":"2474160744","title":"Ligand Pharmaceuticals Incorporated跌3.15% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2474160744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474160744?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:20","pubTimestamp":1728570024,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时20分，Ligand Pharmaceuticals Incorporated股票出现波动，股价大幅下挫3.15%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为252.33%、138.50%、105.64%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 、Genenta Science Spa，振幅分别为34.74%、29.89%、25.48%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102220259719f896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102220259719f896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","BK4139","BK4007","LGND","LGNYZ","LU0566484027.USD","LGNZZ","LGNXZ","LGNDZ"],"gpt_icon":0},{"id":"2472356498","title":"Ligand Pharmaceuticals Incorporated涨3.04% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356498?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:53","pubTimestamp":1727725985,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时53分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速拉升3.04%。截至发稿，该股报100.33美元/股，成交量3.6676万股，换手率0.20%，振幅2.30%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.34%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010353069719da80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010353069719da80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNXZ","LGNYZ","LGND","LU1559883803.SGD","LGNDZ","BK4139","LU0566484027.USD","LGNZZ","BK4007"],"gpt_icon":0},{"id":"2470737931","title":"Ligand Pharmaceuticals Incorporated涨1.49% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2470737931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470737931?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:01","pubTimestamp":1727359316,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日22时01分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速上涨1.49%。截至发稿，该股报100.26美元/股，成交量3355股，换手率0.02%，振幅1.58%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.10%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926220156ab6632cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926220156ab6632cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGNZZ","LGND","LU1559883803.SGD","BK4007","LU0566484027.USD","LGNYZ","LGNXZ","LGNDZ"],"gpt_icon":0},{"id":"2469123148","title":"Ligand Pharmaceuticals Incorporated跌2.74% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2469123148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469123148?lang=zh_cn&edition=full","pubTime":"2024-09-24 01:52","pubTimestamp":1727113955,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日01时52分，Ligand Pharmaceuticals Incorporated股票出现波动，股价快速下跌2.74%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为2.07%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Serina Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为316.37%、71.82%、70.82%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Serina Therapeutics, Inc.，振幅分别为74.90%、57.08%、45.62%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924015235ab656387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924015235ab656387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1559883803.SGD","BK4139","BK4007","LGND","LGNYZ","LU0566484027.USD","LGNZZ","LGNXZ","LGNDZ"],"gpt_icon":0},{"id":"2459472729","title":"Ligand Pharmaceuticals Incorporated2024财年第二财季实现净利润-51.91百万美元，同比减少2366.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459472729","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459472729?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:00","pubTimestamp":1723737641,"startTime":"0","endTime":"0","summary":"8月16日，Ligand Pharmaceuticals Incorporated公布财报，公告显示公司2024财年第二财季净利润为-51.91百万美元，同比减少2366.81%；其中营业收入为41.53百万美元，同比增加57.49%，每股基本收益为-2.88美元。从资产负债表来看，Ligand Pharmaceuticals Incorporated总负债91.21百万美元，其中短期债务1.17百万美元，资产负债比为0.10，流动比率为0.17。机构评级：截至2024年8月16日，当前有6家机构对Ligand Pharmaceuticals Incorporated目标价做出预测，其中目标均价为124.00美元，其中最低目标价为110.00美元，最高目标价为144.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000045959be3e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000045959be3e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LGND","LGNYZ","LGNXZ","LGNDZ"],"gpt_icon":0},{"id":"2459047970","title":"Ligand Pharmaceuticals Incorporated盘中异动 快速上涨5.08%报106.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459047970","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459047970?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:57","pubTimestamp":1723733827,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时57分，Ligand Pharmaceuticals Incorporated股票出现异动，股价急速上涨5.08%。截至发稿，该股报106.15美元/股，成交量3.7877万股，换手率0.21%，振幅3.25%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.73%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225708a1d4746e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225708a1d4746e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNDZ","BK4139","LGNYZ","LGNZZ","LGNXZ","BK4007","LU0566484027.USD","LU1559883803.SGD","LGND"],"gpt_icon":0},{"id":"2459097269","title":"Ligand Pharmaceuticals Incorporated涨0.50% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2459097269","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459097269?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555946,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Ligand Pharmaceuticals Incorporated股票出现波动，股价急速拉升0.50%。截至发稿，该股报100.10美元/股，成交量737股，换手率0.00%，振幅0.00%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为0.34%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132269595702e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132269595702e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNYZ","LGNXZ","LGND","BK4007","BK4139","LGNDZ","LGNZZ","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2458898609","title":"Ligand Pharmaceuticals Incorporated跌0.15% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2458898609","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458898609?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:01","pubTimestamp":1723471297,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时01分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅跳水0.15%。截至发稿，该股报100.00美元/股，成交量9256股，换手率0.05%，振幅3.06%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为0.90%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220138aefe6c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220138aefe6c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGNXZ","LGNYZ","LU0566484027.USD","LGNDZ","LGNZZ","LU1559883803.SGD","LGND","BK4007"],"gpt_icon":0},{"id":"2457725520","title":"Ligand Pharmaceuticals Incorporated涨2.14% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2457725520","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457725520?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:12","pubTimestamp":1722967925,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日02时12分，Ligand Pharmaceuticals Incorporated股票出现异动，股价大幅上涨2.14%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体涨幅为1.94%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1405.00%、1378.40%、515.13%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021206af96376a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021206af96376a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGNZZ","LU1559883803.SGD","BK4139","LGNXZ","LGNDZ","BK4007","LGNYZ","LGND","LU0566484027.USD"],"gpt_icon":0},{"id":"2457775648","title":"Ligand Pharmaceuticals Incorporated盘中异动 股价大跌7.18%报93.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775648","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775648?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865103,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Ligand Pharmaceuticals Incorporated股票出现波动，股价大幅跳水7.18%。Ligand Pharmaceuticals Incorporated股票所在的生物技术行业中，整体跌幅为1.94%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1068.42%、51.78%、14.09%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Ligand Pharmaceuticals Incorporated公司简介：Ligand Pharmaceuticals是一家专注于药物生成科技开发和收购的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213823957f3231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213823957f3231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LGND","BK4139","LGNZZ","LGNDZ","LGNYZ","LGNXZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ligand.com","stockEarnings":[{"period":"1week","weight":-0.0585},{"period":"1month","weight":-0.0487},{"period":"3month","weight":0.1478},{"period":"6month","weight":0.3771},{"period":"1year","weight":0.5855},{"period":"ytd","weight":0.5875}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ligand Pharmaceuticals Incorporated于1987年在特拉华州注册，是一家生物制药公司。公司商业模式为，开发或收购能产生收益的资产，将其融合到精益企业的成本结构中。公司的目标是创造可持续盈利的业务以生成股东价值。由于公司的商业模式是基于与其他制药公司合作，商业化利用并销售资产，因此公司不少收入来自合作伙伴提供的相关使用费。公司认识到了制药行业药物重制的重要性，2011年将CAPTISOL项目加入到技术投资中。CAPTISOL是一个功能强大的配方技术，拥有5个美国食品药品管理局批准的产品，包括Pfizer公司的VFEND IV和Baxter International公司的Nexterone，以及其他一些在临床阶段投入使用的合作伙伴项目。与同行的其他公司相比，公司已经组建了一个最大的行业多元化资产组合，在未来能产生显著的收益。资产组合中发展的治疗方案可以解决许多尚未得到解决的医疗需求缺口，包括肝炎、肌肉萎缩、老年痴呆症、血脂异常、糖尿病、贫血、哮喘、类风湿关节炎、和骨质疏松症。","yearOnYearQuotes":[{"month":1,"riseRate":0.413793,"avgChangeRate":0.002629},{"month":2,"riseRate":0.448276,"avgChangeRate":0.016542},{"month":3,"riseRate":0.551724,"avgChangeRate":0.034987},{"month":4,"riseRate":0.517241,"avgChangeRate":0.005444},{"month":5,"riseRate":0.482759,"avgChangeRate":0.02555},{"month":6,"riseRate":0.633333,"avgChangeRate":0.057096},{"month":7,"riseRate":0.466667,"avgChangeRate":-0.014553},{"month":8,"riseRate":0.533333,"avgChangeRate":-0.026081},{"month":9,"riseRate":0.366667,"avgChangeRate":0.001465},{"month":10,"riseRate":0.586207,"avgChangeRate":-0.001773},{"month":11,"riseRate":0.482759,"avgChangeRate":0.025354},{"month":12,"riseRate":0.666667,"avgChangeRate":0.05229}],"exchange":"NASDAQ","name":"Ligand Pharmaceuticals Inc.","nameEN":"Ligand Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ligand Pharmaceuticals Inc.(LGND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ligand Pharmaceuticals Inc.(LGND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ligand Pharmaceuticals Inc.,LGND,Ligand Pharmaceuticals Inc.股票,Ligand Pharmaceuticals Inc.股票老虎,Ligand Pharmaceuticals Inc.股票老虎国际,Ligand Pharmaceuticals Inc.行情,Ligand Pharmaceuticals Inc.股票行情,Ligand Pharmaceuticals Inc.股价,Ligand Pharmaceuticals Inc.股市,Ligand Pharmaceuticals Inc.股票价格,Ligand Pharmaceuticals Inc.股票交易,Ligand Pharmaceuticals Inc.股票购买,Ligand Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ligand Pharmaceuticals Inc.(LGND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ligand Pharmaceuticals Inc.(LGND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}